Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
francesco.marampon@uniroma1.it
Francesco Marampon
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE RADIOLOGICHE, ONCOLOGICHE E ANATOMO-PATOLOGICHE
E-mail:
francesco.marampon@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
A pilot surveillance investigation on the influence of a probiotic combination on side-effects caused by common anti-cancer therapies
Reports of Practical Oncology Radiotherapy
2022
Phosphodiesterase type-5 inhibitor tadalafil modulates steroid hormones signaling in a prostate cancer cell line
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021
MiR-200c-3p contrasts PD-L1 induction by combinatorial therapies and slows proliferation of epithelial ovarian cancer through downregulation of β-Catenin and c-Myc
CELLS
2021
OTX015 epi‐drug exerts antitumor effects in ovarian cancer cells by blocking GNL3‐mediated radioresistance mechanisms: Cellular, molecular and computational evidence
CANCERS
2021
Adjuvant vaginal interventional radiotherapy in early-stage non-endometrioid carcinoma of corpus uteri: a systematic review
JOURNAL OF CONTEMPORARY BRACHYTHERAPY
2021
Muscle damage in systemic sclerosis and CXCL10: the potential therapeutic role of PDE5 inhibition
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021
Dnmt3a and dnmt3b targeting as an effective radiosensitizing strategy in embryonal rhabdomyosarcoma
CELLS
2021
Strategies for bone regeneration: from graft to tissue engineering
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021
Multiple antitumor molecular mechanisms are activated by a fully synthetic and stabilized pharmaceutical product delivering the active compound sulforaphane (SFX-01) in preclinical model of human glioblastoma
PHARMACEUTICALS
2021
Deep seated tumour treatments with electrons of high energy delivered at FLASH rates: the example of prostate cancer
FRONTIERS IN ONCOLOGY
2021
Treatment in locally advanced rectal cancer: a machine learning bibliometric analysis
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY
2021
MS−275 (Entinostat) promotes radio-sensitivity in PAX3-FOXO1 rhabdomyosarcoma cells
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
2021
Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and Heterodimers
BIOMOLECULES
2021
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair
CANCER LETTERS
2021
Recommendation for the contouring of limbic system in patients receiving radiation treatment: A pictorial review for the everyday practice and education
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2021
Sildenafil Counteracts the In Vitro Activation of CXCL-9, CXCL-10 and CXCL-11/CXCR3 Axis Induced by Reactive Oxygen Species in Scleroderma Fibroblasts
BIOLOGY
2021
Locally advanced rectal cancer. Treatment approach in elderly patients
CURRENT TREATMENT OPTIONS IN ONCOLOGY
2020
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY ONLINE
2020
BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells
CANCER LETTERS
2020
« prima
< precedente
1
2
3
4
5
6
7
seguente ›
ultima »
Progetti di Ricerca
Coding and non-coding genes driving radio-resistance mechanisms in rhabdomyosarcoma tumors: cues to new biomarkers and therapeutic targets.
Identifying and targeting pathways involved in radio-resistance in pediatric rhabdomyosarcoma
HDACs inhibitors as radiosensitizers for rhabdomyocarcoma cancer therapy
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma